文献速递外周动脉疾病

病态肥胖与超级肥胖患者下肢旁路及外周血管介入的围术期结局

Perioperative outcomes after lower extremity bypass and peripheral vascular interventions in patients with morbid obesity and superobesity.
PubMed 文献 · J Vasc Surg · 2019-08-20

基于血管质量倡议(VQI)2010–2017年数据,分析病态肥胖(BMI 40–49.9 kg/m2)与超级肥胖(BMI ≥50 kg/m2)患者下肢旁路(LEB)和外周血管介入(PVI)的围术期结局。多变量分析显示,病态肥胖与超级肥胖仅与LEB后手术部位感染和呼吸并发症风险增加显著相关,与PVI后不良事件无显著关联。

要点

  • 病态肥胖与超级肥胖不应单独作为阻碍必要血运重建的因素。

核心结论

  • 病态肥胖与超级肥胖与LEB后手术部位感染和呼吸并发症发生率增加显著相关,但与PVI后不良事件无显著关联。
  • 病态肥胖与超级肥胖患者合并症更多、血管病变表现更晚期,但肥胖本身不应妨碍必要的血运重建。

研究设计与样本

  • 回顾性队列研究,数据来自血管质量倡议(VQI)2010–2017年所有腹股沟下外周动脉疾病干预病例。
  • 共纳入29138例LEB(非肥胖68.5%、肥胖28.3%、病态肥胖2.9%、超级肥胖0.3%)和81405例PVI(非肥胖66.6%、肥胖29.2%、病态肥胖3.6%、超级肥胖0.5%)。
  • 按BMI分为四组:非肥胖(18.5–29.9 kg/m2)、肥胖(30–39.9 kg/m2)、病态肥胖(40–49.9 kg/m2)、超级肥胖(≥50 kg/m2),统计分析时将病态肥胖与超级肥胖合并。
  • 采用多变量分析评估结局。

主要发现

  • 病态肥胖与超级肥胖患者更年轻、女性比例更高、不吸烟、可步行,且糖尿病、终末期肾病、充血性心力衰竭比例更高、既往流入道手术更少(P < .05)。
  • 病态肥胖与超级肥胖患者的LEB和PVI较少为择期手术,更多因组织缺损而实施。
  • 多变量分析显示,病态肥胖与超级肥胖与LEB后围术期心脏并发症、重返手术室或死亡率无显著关联。
  • 病态肥胖与超级肥胖与LEB后手术部位感染(OR 1.43,95%CI 1.02–1.98,P = .03)和呼吸并发症(OR 1.6,95%CI 1.11–2.31,P = .01)风险增加显著相关。
  • 多变量分析显示,病态肥胖与超级肥胖与PVI后穿刺点血肿、穿刺点狭窄或闭塞或死亡率无显著关联。

临床怎么用

  • 对病态肥胖与超级肥胖患者行LEB时,应加强手术部位感染预防和呼吸并发症管理。
  • 病态肥胖与超级肥胖本身不应作为拒绝必要血运重建的理由。
  • PVI在病态肥胖与超级肥胖患者中未显示与不良围术期事件显著相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although the effect of body mass index (BMI) on the treatment of infrainguinal peripheral artery disease has been reported, outcomes of patients on the upper end of the obesity spectrum, including morbid obesity (MO) and superobesity (SO), are unclear. Our goal was to analyze perioperative outcomes after lower extremity bypass (LEB) and peripheral vascular interventions (PVIs) in this population of patients. METHODS: The Vascular Quality Initiative was reviewed for all infrainguinal peripheral artery disease interventions from 2010 to 2017. All patients were categorized into four groups: nonobese (BMI 18.5-29.9 kg/m2), obese (BMI 30-39.9 kg/m2), morbidly obese (BMI 40-49.9 kg/m2), and superobese (BMI ≥50 kg/m2). Patient and case details were recorded. Multivariable analysis was used to analyze outcomes. For statistical analysis, MO and SO groups were combined. RESULTS: We identified 29,138 LEB cases (68.5% nonobese, 28.3% obese, 2.9% morbidly obese, 0.3% superobese) and 81,405 PVI cases (66.6% nonobese, 29.2% obese, 3.6% morbidly obese, 0.5% superobese). For both LEB and PVI, patients with MO and SO were more likely to be younger, female, nonsmokers, and ambulatory (P < .05). They also more often had diabetes, end-stage renal disease, congestive heart failure, and fewer previous inflow procedures (P < .05). LEB and PVI interventions in patients with MO and SO were less often elective and more often performed for tissue loss. Multivariable analysis showed that LEB in patients with MO and SO was not significantly associated with increased perioperative cardiac complications, return to the operating room, or mortality. Patients with MO and SO were significantly associated with increased surgical site infection (odds ratio, 1.43; 95% confidence interval, 1.02-1.98; P = .03) and increased respiratory complications (odds ratio, 1.6; 95% confidence interval, 1.11-2.31; P = .01). Multivariable analysis showed that MO and SO were not significantly associated with periprocedural access site hematoma, access site stenosis or occlusion, or mortality after PVI. CONCLUSIONS: MO and SO were significantly associated with increased incidence of wound infections and respiratory complications after LEB but were not significantly associated with increased incidence after PVI. Overall, patients with MO and SO have more comorbidities and more advanced presentation of vascular disease at the time of intervention, but MO and SO alone should not deter necessary and appropriate revascularization.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Arinze N, Farber A, Levin SR, et al. Perioperative outcomes after lower extremity bypass and peripheral vascular interventions in patients with morbid obesity and superobesity. J Vasc Surg. 2019. PMID: 31443977. doi:10.1016/j.jvs.2019.05.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。